China’s APEC Investment Pledge: What Changed for Foreign Investors in 2026

China’s APEC CEO Summit message matters: it is a public commitment to remain open to foreign capital at a time when boardrooms are reweighing Asia-Pacific strategy. For investor migration counsel, the signal translates into practical next steps — mapping viable entry routes, aligning compliance workflows, and targeting sectors China is explicitly opening.

This article breaks down the regulatory shifts, FDI data, entity formation options, and talent mobility changes that counsel and investors need to understand heading into 2026.

Table of contents

• APEC Summit messaging: China’s pitch to global investors
• Regulatory liberalization: understanding the negative lists
• FDI trends and Beijing’s response
• National treatment and reinvestment incentives
• 2025 Encouraged Catalogue: priority sectors for 2026
• Market entry: entity formation options
• Key compliance requirements for foreign investors
• Talent mobility: the new K visa
• China vs Asia-Pacific alternatives
• Action checklist for inbound counsel
• Frequently asked questions

APEC Summit messaging: China’s pitch to global investors

Speaking at the 2025 APEC CEO Summit in Gyeongju, South Korea, China characterized itself as an “ideal, safe, and promising” destination for global investors and pledged to keep markets open. The commitment was explicit: continued liberalization, enhanced national treatment, and expanded talent facilitation. APEC economies account for roughly half of global trade, underscoring that strategic positioning in the Asia-Pacific is synonymous with positioning in world commerce.

Crucially, no brand-new FDI legislation was announced at the Summit itself. The messaging reinforced measures already adopted through 2025 — the shortened negative list, national treatment guarantees under the Foreign Investment Law, and the K visa for STEM talent. For counsel, the Summit’s significance lies in political signaling: China is doubling down on openness at a time of geopolitical tension and declining FDI inflows.

For investor migration advisors, this is a signal to reengage clients on China-side market entry and mobility planning — particularly where cross-border talent and capital flows drive value creation.

Regulatory liberalization: understanding the negative lists

China maintains two distinct negative lists that are frequently confused in reporting. Understanding the difference is essential for accurate client advice:

The Foreign Investment Access Negative List (the list that matters most for FDI) was reduced to just 29 items in its 2024 edition, effective November 1, 2024. This is the list that determines which sectors are restricted or prohibited for foreign investors specifically. Manufacturing has been fully removed — meaning 100% foreign ownership is now permitted across all manufacturing sub-sectors.

The broader Market Access Negative List (which applies to all investors, domestic and foreign) was trimmed from 117 to 106 items in its April 2025 edition across 21 industry sections. This list governs general market entry, not foreign-specific restrictions.

When Xi Jinping stated at APEC that “only 29 items remain on China’s negative list,” he was referencing the Foreign Investment Access list — the instrument directly relevant to foreign investors. Sectors newly opened or further liberalized include advanced manufacturing, TV production, certain telecom value-added services, online healthcare and pharma information services, and specialized healthcare (elderly care, rehabilitation).

For counsel, fewer restricted sectors mean a broader menu of structuring options — wholly foreign-owned enterprises (WFOEs), joint ventures, M&A, and strategic partnerships — and a greater need to align governance and compliance from day one.

FDI trends and Beijing’s response

China’s FDI inflows have continued to soften. Full-year 2025 actual utilization of foreign direct investment reached 747.69 billion yuan, down 9.5% year-on-year according to MOFCOM. Manufacturing accounted for 185.51 billion yuan and services 545.12 billion yuan. The most recent available data for January–February 2026 shows 161.45 billion yuan in utilized FDI, down 5.7% year-on-year — a narrowing decline that suggests stabilization may be underway.

However, a counterpoint to the headline decline: the number of newly established foreign-invested enterprises in 2025 reached 70,392 — up 19.1% year-on-year. This divergence — declining capital volume but surging new entity formation — suggests that foreign investors are entering the market in greater numbers, albeit with smaller initial commitments. November 2025 alone saw a 26.1% year-on-year rebound in monthly FDI inflows.

The policy response has emphasized stability and predictability for multinationals, including assurances on market access, equal treatment, profit repatriation rights, and expanded incentives for reinvestment — signals that inform risk assessment and client communications.

National treatment and reinvestment incentives

National treatment for foreign-invested enterprises is codified in Article 4 of the Foreign Investment Law (FIL), which establishes a pre-establishment national treatment framework combined with the negative list approach. This is not merely aspirational — it is binding law. Equal treatment extends to government procurement, standard-setting, and policy support programs. The FIL also prohibits forced technology transfers and protects intellectual property and trade secrets.

On reinvestment, China introduced a 10% enterprise income tax (EIT) credit for foreign investors who reinvest distributed profits into qualifying domestic equity investments in Encouraged Catalogue sectors. This incentive runs from January 2025 through December 2028, with carry-forward provisions. Additionally, domestic loans are now available to foreign-invested enterprises for equity investment, and simplified foreign exchange procedures support reinvestment.

For counsel, this framework invites structuring that prioritizes retained earnings, dividend cycling, and expansion reinvestment — while validating long-term operating footprints over short-term opportunism.

Policy signal to counsel: a quick-action mapping

2025 Encouraged Catalogue: priority sectors for 2026

The 2025 Encouraged Catalogue of Industries for Foreign Investment was issued in December 2025 and took effect on February 1, 2026, replacing the 2022 edition. It includes 205 net new entries and 303 revisions, representing the most significant expansion in years.

Priority sectors include:

Advanced manufacturing — end products, components, and raw materials across the full manufacturing value chain. With manufacturing fully removed from the FI Access Negative List, 100% foreign ownership is available across all sub-sectors.

Modern service industries — business services, technical services, scientific research, maritime logistics, and virtual power plant operations. These reflect China’s push to upgrade its service economy.

High technology — artificial intelligence, 5G infrastructure, biotechnology, and next-generation IT. These sectors benefit from both Encouraged Catalogue incentives and Free Trade Zone (FTZ) pilot programs.

Green development — renewable energy, environmental technology, energy conservation, and green finance. These align with China’s dual carbon goals and attract preferential tax treatment.

Regional targeting — the catalogue continues to incentivize investment in central, western, and northeastern China with additional preferential policies, including reduced corporate income tax rates (15% vs the standard 25%) in designated areas.

Sector-specific considerations

Telecoms: Basic telecommunications remains largely prohibited for foreign investors outside FTZs. However, value-added telecom services (VATS) have a 50% foreign ownership cap at the national level, with FTZ pilots allowing 100% WFOE ownership for certain VATS categories. Counsel should map licensing frameworks and residual caps before selecting an entry mode.

Biotech: Human genetic and stem cell technology remains prohibited, but 2025–2026 pilot programs have opened biopharmaceutical segmented production and FTZ pilots for cell/gene therapy and wholly foreign-owned hospitals. Structure collaborations to protect IP and account for regulated data flows in clinical and real-world evidence environments.

Healthcare: At the national level, medical institutions still require joint venture structures. FTZ pilots now permit wholly foreign-owned hospitals in designated areas — a significant development for healthcare investors willing to locate within FTZ boundaries.

Market entry: entity formation options

Foreign investors entering China have several structural options, each with distinct implications for control, liability, and regulatory treatment:

Wholly Foreign-Owned Enterprise (WFOE): 100% foreign equity in permitted sectors. Since post-Company Law reforms, the statutory minimum capital requirement has been largely abolished for most sectors, with practical ranges of CNY 100,000–500,000 for service-oriented WFOEs. Timeline to operational status is typically 1.5 to 2 months, covering business license issuance (approximately 20 working days), followed by bank account setup, tax registration, and HR filing.

Joint Venture (JV): Required in several restricted sectors where WFOEs are not permitted. The foreign party typically holds at least 25% of registered capital to qualify for foreign-invested enterprise status and associated benefits.

Representative Office: No registered capital required, but limited to liaison, market research, and coordination activities. A representative office cannot invoice clients, sign contracts, or generate revenue directly.

Variable Interest Entity (VIE): A contractual control structure commonly used in sectors like internet services where direct foreign ownership faces restrictions. The WFOE component follows standard capital rules, while the domestic operating company meets sector-specific requirements.

For clients evaluating China market entry, the choice between structures depends on the target sector, regulatory landscape, ownership requirements, and long-term objectives. At Vardanyan & Partners, we help international clients structure cross-border operations that comply with both their home-country and destination-country requirements — whether they are entering China from Armenia, establishing regional headquarters, or coordinating multi-jurisdictional group structures. See our business registration and tax advisory services for related guidance.

Key compliance requirements for foreign investors

Foreign investors operating in China must navigate an increasingly complex compliance landscape:

Cybersecurity Law: Critical information infrastructure operators must store personal information and important data locally within China. A security assessment is required before any cross-border data transfer. In practice, data localization requirements are expanding beyond the narrow definition of critical infrastructure operators.

Data Security Law (DSL): Establishes tiered protection for “core data” and “important data,” with national security review requirements. The evolving “important data” catalogues continue to be refined — counsel should monitor developments closely.

Personal Information Protection Law (PIPL): China’s omnibus personal data law requires lawful basis and consent for data processing, with specific cross-border transfer mechanisms including CAC security assessments, standard contractual clauses, and certification.

Anti-Monopoly Law: Applies equally to foreign and domestic enterprises. The State Administration for Market Regulation (SAMR) actively enforces merger control and has increased scrutiny of digital platforms and self-preferencing behavior. Foreign investors involved in M&A transactions should factor in SAMR review timelines.

Free Trade Zones (FTZs): FTZs apply shorter negative lists and pilot sector-specific openings not available at the national level. The most relevant FTZs for foreign investors include Shanghai (including Lingang) for VATS, financial services, and biomedicine; Hainan Free Trade Port for healthcare tourism and internet pilots; and provincial FTZs in Beijing, Guangdong, and Tianjin for sector-specific liberalization.

Talent mobility: the new K visa

China introduced the K visa through a State Council decree published on August 14, 2025, effective October 1, 2025. The K visa targets “foreign young science and technology talent” and represents a significant departure from China’s traditional employer-sponsored immigration framework.

Key confirmed features: The K visa does not require a Chinese employer or invitation unit at the application stage — making it the first employer-independent visa category for working-age professionals in China’s immigration system. Applications are processed through an upgraded e-visa portal with reusable biometrics.

Reported operational parameters (based on March 2026 clarifications, pending full primary source verification): eligibility extends to STEM bachelor’s degree holders from recognized universities and research institutes worldwide, or researchers under 40 with at least two years of relevant experience. The visa is reported to offer multi-entry validity of up to five years with stays of up to 180 days per entry.

Important distinction regarding work authorization: The K visa allows entry into China for talent-search purposes, but it does not grant automatic work authorization. Under China’s Exit-Entry Administration Law, formal employment still requires obtaining a work permit and work-type residence permit after arrival. This is a critical distinction for counsel advising clients — the K visa facilitates entry and job seeking, not immediate employment.

K visa vs existing visa categories

Counsel should integrate mobility into market-entry timelines by sequencing entity setup, employment contracts, and visa/permit applications for executives and specialists. For portfolio teams routing through the Asia-Pacific region, comprehensive mobility planning — including alternative residency bases — can de-risk travel and staffing. See our residence permits and work permits services for related Armenia-based mobility options.

China vs Asia-Pacific alternatives

For investors evaluating the broader Asia-Pacific, China offers unparalleled market scale and supply chain depth — but also the most complex regulatory environment. A comparative perspective helps counsel frame client advice:

For clients building multi-jurisdictional strategies, Armenia increasingly serves as a complementary base for regional operations — offering streamlined residence by investment, competitive tax rates, and access to European markets via association agreements. See our citizenship and digital nomad visa pages for more on Armenia-based options.

Action checklist for inbound counsel

• Map China-facing investor pathways by sector and entry mode, reflecting the 29-item FI Access Negative List and 2025 Encouraged Catalogue.
• Refresh cross-border KYC and source-of-funds workflows for onboarding, banking, and capital movements.
• Prepare client briefings that align deal theses with regulatory readiness — licensing, data compliance, and governance.
• Prioritize origination in Encouraged Catalogue sectors: advanced manufacturing, AI, biotech, green technology, and modern services.
• Integrate K visa mobility planning into project critical paths — remembering that a separate work permit is still required for employment.
• Model reinvestment structures to leverage the 10% EIT credit (2025–2028) and national treatment commitments.
• Evaluate Free Trade Zone opportunities for sectors with remaining national-level restrictions (healthcare, telecoms VATS, financial services).
• Assess data compliance requirements (Cybersecurity Law, DSL, PIPL) for any operations involving cross-border data transfers.

Why this is an Asia-Pacific strategy moment

APEC’s scale — roughly half of global trade — means China’s openness posture reverberates beyond one market, shaping supply chains, capital allocation, and talent deployment across the region. Recent bilateral investment treaties (China-Singapore FTA updated effective December 31, 2024; new BITs with Angola and Venezuela) and the APEC Business Travel Card system continue to reduce friction for cross-border business mobility.

For investor migration counsel, this is the time to integrate China inbound investment planning with wider Asia-Pacific mobility and corporate structuring — so clients can move capital and people with confidence.

Frequently asked questions